MannKind Corporation
USD4.24
+0.10 (+2.42%)
CEO
Michael E. Castagna
IPO Date
2004-07-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.10
Prev. Close
$4.14
Day Low
$4.06
Day High
$4.25
52W Low
$2.23
52W High
$6.51
Market Cap
$1.31B
Volume
3.26M
| 64.0 |
| 31 Dec 2023 | FY | 68.5% | -6.0% | 4.8% | -2.5% | -1.11 | 3.59 | -81.4 |
| 31 Dec 2022 | FY | 42.4% | -87.6% | 34.9% | -29.6% | -1.15 | 3.49 | -15.5 |
| 31 Dec 2021 | FY | 48.5% | -107.3% | 38.7% | -25.2% | -1.38 | 4.54 | -13.5 |
| 31 Dec 2020 | FY | 62.2% | -87.9% | 31.7% | -52.7% | -0.68 | 1.08 | -12.2 |
| 31 Dec 2019 | FY | 55.6% | -82.3% | 27.2% | -55.4% | -0.64 | 0.93 | -4.9 |
| 31 Dec 2018 | FY | 26.5% | -312.2% | 49.7% | -80.8% | -0.59 | 1.09 | -1.8 |
| 31 Dec 2017 | FY | -46.7% | -999.0% | 54.6% | -138.7% | -0.73 | 0.65 | -2.1 |
| 31 Dec 2016 | FY | 71.3% | 71.9% | -68.4% | 117.4% | -0.81 | 0.84 | 2.3 |
| -27.2 |
| 30 Sept 2025 | Q3 | 75.4% | 9.7% | -17.9% | 1.6% | -5.07 | 3.29 | 51.6 |
| 30 Jun 2025 | Q2 | 73.1% | 0.9% | -1.2% | 0.2% | -0.85 | 2.50 | 426.8 |
| 31 Mar 2025 | Q1 | 77.6% | 16.8% | -22.4% | 3.2% | -0.81 | 2.36 | 29.0 |
| 31 Dec 2024 | Q4 | 74.5% | 9.7% | -9.4% | 1.9% | -1.99 | 3.28 | 60.5 |
| 30 Sept 2024 | Q3 | 74.3% | 16.5% | -5.5% | 2.5% | -1.14 | 4.54 | 37.4 |
| 30 Jun 2024 | Q2 | 71.8% | -2.8% | 0.9% | -0.5% | -1.02 | 4.07 | -172.5 |
| 31 Mar 2024 | Q1 | 71.9% | 16.0% | -4.6% | 2.2% | -1.16 | 3.84 | 27.6 |
| 31 Dec 2023 | Q4 | 69.1% | 2.4% | -0.6% | 0.3% | -1.11 | 3.59 | 175.1 |